Fundz

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer

PUBLIC · RCUSJan 21, 2025

Position

Chief Medical Officer

Company

Arcus Biosciences

Richard Markus
HaywardBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Arcus Biosciences, Inc. announced the appointment of Richard Markus, M.D., Ph.D., as chief medical officer (CMO) effective January 31, 2025, replacing Dimitry Nuyten, M.D., Ph.D

Who to call at Arcus Biosciences, and when

A new leader at Arcus Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Arcus Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arcus Biosciences, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arcus Biosciences

Location

Hayward, California, United States

About

Arcus Biosciences, Inc. is a clinical-stage, global biopharmaceutical company, focused on developing differentiated molecules and combination therapies for people with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arcus Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Arcus Biosciences's next move

Learn about Strategic plan

Arcus Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.